Study Detail

OCTAVE

Observational Cohort Trial -T-cells Antibodies and Vaccine Efficacy in SARS-CoV-2

Status: Open

Type: not available

Funder: NIHR / UKRI

Sponsor: University of Birmingham

CI: Prof Iain McInnes

IRAS-Number: 294480

CPMS-ID: 48426

Approval Date: 01 March 2021

Study URL:

https://www.birmingham.ac.uk/news/latest/2021/03/covid-vaccine-immune-cancer-patients.aspx

Back to listing